Synapse Mobility (Global) 6.2.0

License: Free ‎File size: N/A
‎Users Rating: 0.0/5 - ‎0 ‎votes

Synapse™ Mobility provides access to FUJIFILM's Synapse product suite using hand-held mobile devices, providing Radiologists and Physicians with on-the-go access to the images and information stored within FUJIFILM systems. The Synapse Mobility application provides interactive three dimensional images for iPhone® and iPad® allowing images to be manipulated using the 2D, 3D, and MIP/MPR feature sets within the app. Synapse Mobility Version 6.2.0 (Android Client Version 6.2.0) - Support for Samsung Galaxy S8 - Support for Google Pixel C - Support for Nexus Phone 6p - Cine Enhancements - Automatically start motion studies and comparison of multiple Cine streams. - Measurements - Mobile device measurement support. - Audio / Video - Collaboration functionality now includes embedded audio / video. - Secure URL Launch with Epic Integration - Data encryption is used to securely create URLs for launching studies from third party applications, including EPIC's EMR System. - Non-DICOM Data - Supported is added to view non-DICOM images and video formats (JPG, PNG, TIFF, MP4, MPG) - Image Stack Navigation - 2D image sets are organized into stacks instead and navigated through with hand gestures. - Image Printing - Print images from the image viewer. - GSPS - Greyscale Soft Copy Presentation State (GSPS) support. - Reference Lines - Display of scout lines and images allows for quick reference of slice position. Selecting either a slice or scout line provides a visual indicator of position.

VERSION HISTORY

  • Version 5.3.3 (Rev posted on 2016-07-06
    What's New in Synapse Mobility Version 5.3.2 (Android Client Version 5.3.3):,- Cine Enhancements,- Measurements - Mobile device measurement support,- Audio / Video - Collaboration,- Secure URL Launch with Epic Integration,- Non-DICOM Data formats (JPG, PNG, TIFF, MP4, MPG),- Image Stack Navigation - 2D image sets, Image Printing,- GSPS - Greyscale Softcopy Presentation State (GSPS) support,- Reference Lines,- FDA Class II Diagnostic approval on all modalities (minus MG)

Program Details